Search Results 1541-1550 of 27388 for female
Female aged 21-65 years who reported being up-to-date with cervical cancer screening. State. Lung & Bronchus. 59.4. 38.5. Target. 84.2%. 77.8%. 84.3%. Colon & ...
Female aged 21-65 years who reported being up-to-date with cervical cancer screening. State. Lung & Bronchus. 50.4. 29.2. Target. 83.7%. 78.7%. 84.3%. Colon & ...
Female aged 21-65 years who reported being up-to-date with cervical cancer screening. State. 52.7. 35.0. Target. 85.1%. 77.2%. 84.3%. Melanoma of the Skin. 46.9.
Female aged 21-65 years who reported being up-to-date with cervical cancer ... Female aged 50-74 years who. State. 79.0%. Kidney & Renal Pelvis. 19.7. 3.2.
Female aged 21-65 years who reported being up-to-date with cervical cancer screening. State. 53.4. 33.6. Target. 85.2%. 77.8%. 84.3%. Colon & Rectum. 41.9. 0.0.
Female aged 21-65 years who reported being up-to-date with cervical cancer screening. State. Colon & Rectum. 60.7. 22.9. Target. 77.2%. 84.3%. Melanoma of the ...
Female aged 21-65 years who reported being up-to-date with cervical cancer screening. State. Lung & Bronchus. 41.7. 28.6. Target. 84.1%. 78.7%. 84.3%. Bladder.
Female subjects of childbearing potential with fertile male partners must agree to use contraception consistently from screening until the final study visit ...
Female subjects must have negative urine pregnancy tests and must not be lactating prior to receiving study medication and radiation exposure; For females ...
... female sex, reproductive history and radiologic phenotypic variability in MS, and to explore the association between female sex, genetic and environmental ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!